ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA)

CUSIP: 488445206

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
58,397,755
Total 13F shares
38,147,770
Share change
-1,761,882
Total reported value
$341,794,447
Put/Call ratio
65%
Price per share
$8.96
Number of holders
159
Value change
-$17,168,035
Number of buys
79
Number of sells
81

Security key

488445206

Report period

Q4 2025

Institutions

159

Top holders

10

Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
7.6%
from 13D/G
4,037,154
$38,393,334 30 Sep 2025
Woodline Partners LP
13F 13D/G
Company
6.2%
from 13D/G
3,476,143
$33,058,120 30 Sep 2025
Nantahala Capital Management, LLC
13F 13D/G
Company
4.4%
from 13D/G
1,971,936
$18,753,112 30 Sep 2025
Adage Capital Management, L.P.
13D/G
4%
2,225,000
$21,159,750 -$13,551,750 30 Sep 2025
VANGUARD GROUP INC
13F
Company
5.3%
3,083,362
$29,322,773 30 Sep 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3.8%
2,225,000
$21,159,750 30 Sep 2025
13F
FMR LLC
13F
Company
2.8%
1,634,571
$15,544,766 30 Sep 2025
13F
STATE STREET CORP
13F
Company
2.4%
1,427,291
$13,573,537 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
1,300,340
$12,368,921 30 Sep 2025
13F
AIGH Capital Management LLC
13F
Company
2.1%
1,231,932
$11,715,673 30 Sep 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
2.1%
1,205,514
$11,464,438 30 Sep 2025
13F
Legal & General Group Plc
13F
Company
1.8%
1,053,399
$10,017,824 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.8%
1,035,251
$9,845,237 30 Sep 2025
13F
683 Capital Management, LLC
13F
Company
1.7%
975,000
$9,272,250 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
1.6%
912,299
$8,675,963 30 Sep 2025
13F
Stonepine Capital Management, LLC
13F
Company
1.4%
810,000
$7,703,100 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.3%
761,777
$7,244,500 30 Sep 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
1.2%
725,830
$6,902,644 30 Sep 2025
13F
ROYCE & ASSOCIATES LP
13F
Company
1.2%
691,239
$6,573,683 30 Sep 2025
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
1.1%
650,000
$6,181,500 30 Sep 2025
13F
Retirement Planning Co of New England, Inc.
13F
Company
1%
600,770
$5,713,323 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.95%
555,950
$5,287,085 30 Sep 2025
13F
Caption Management, LLC
13F
Company
0.87%
510,091
$4,850,965 30 Sep 2025
13F
TUDOR INVESTMENT CORP ET AL
13F
Company
0.77%
447,896
$4,259,491 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.75%
439,480
$4,179,455 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.75%
438,984
$4,174,739 30 Sep 2025
13F
ALGERT GLOBAL LLC
13F
Company
0.72%
418,550
$3,980,000 30 Sep 2025
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.71%
412,547
$3,935,698 30 Sep 2025
13F
Mystic Asset Management, Inc.
13F
Company
0.59%
346,652
$3,296,661 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0.57%
332,443
$3,161,534 30 Sep 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.52%
306,489
$2,914,710 30 Sep 2025
13F
Trexquant Investment LP
13F
Company
0.52%
302,863
$2,880,227 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.49%
288,045
$2,739,308 30 Sep 2025
13F
Squarepoint Ops LLC
13F
Company
0.46%
268,077
$2,549,412 30 Sep 2025
13F
Propel Bio Management, LLC
13F
Company
0.4%
231,874
$2,205,122 30 Sep 2025
13F
Stratos Wealth Partners, LTD.
13F
Company
0.39%
229,000
$2,177,790 30 Sep 2025
13F
UBS Group AG
13F
Company
0.37%
218,096
$2,074,093 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.37%
214,202
$2,037,061 30 Sep 2025
13F
Verition Fund Management LLC
13F
Company
0.33%
193,509
$1,840,271 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.33%
191,796
$1,823,980 30 Sep 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.32%
187,266
$1,780,900 30 Sep 2025
13F
Janney Montgomery Scott LLC
13F
Company
0.31%
183,701
$1,747,000 30 Sep 2025
13F
Kovack Advisors, Inc.
13F
Company
0.3%
175,283
$1,666,939 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.27%
157,765
$1,500,345 30 Sep 2025
13F
Nuveen, LLC
13F
Company
0.26%
153,032
$1,455,334 30 Sep 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.26%
152,311
$1,448,478 30 Sep 2025
13F
Simplify Asset Management Inc.
13F
Company
0.25%
147,000
$1,397,970 30 Sep 2025
13F
Brevan Howard Capital Management LP
13F
Company
0.22%
130,751
$1,243,442 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.22%
125,831
$1,196,655 30 Sep 2025
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.2%
117,576
$1,118,148 30 Sep 2025
13F

Institutional Holders of ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) as of Q4 2025

As of 31 Dec 2025, ZEVRA THERAPEUTICS, INC. - COMMON STOCK (ZVRA) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,147,770 shares. The largest 10 holders included BlackRock, Inc., Woodline Partners LP, VANGUARD GROUP INC, FMR LLC, Nantahala Capital Management, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and Legal & General Group Plc. This page lists 159 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
164
Q4 2025 holders
159
Holder diff
-5
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .